Induction of resectability of colorectal liver metastases (CLM) with cetuximab (Cmab) plus CPT-11/5-fluorouracil (5-FU)/leucovorin (FA)/oxaliplatin (L-OHP) (CPT-11-FFL) (POCHER trial)

被引：2
|
作者：
Garufi, C. [1 ]
Torsello, A. [1 ]
Tumolo, S. [2 ]
Mottolese, M. [1 ]
Melucci, E. [1 ]
Campanella, C. [1 ]
Zeuli, M. [1 ]
Sperduti, I. [1 ]
Ettorre, G. M. [3 ]
Cognetti, F. [1 ]
机构：
[1] Regina Elena Inst Canc Res, Rome, Italy
[2] Osped SM Angeli, Pordenone, Italy
[3] Osped S Camillo Roma, Rome, Italy
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71181-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：348 / 348
页数：1
相关论文
共 50 条
  • [1] RESECTABILITY OF COLORECTAL LIVER METASTASES (CLM) WITH CETUXIMAB PLUS CPT-11/5-FLUOROURACIL (5-FU)/LEUCOVORIN(FA)/OXALIPLATIN (L-OHP) (CPT-11-FFL) AS NEOADJUVANT TREATMENT (POCHER TRIAL)
    Torsello, A.
    Garufi, C.
    Tumolo, S.
    Melucci, E.
    Conti, S.
    Campanella, C.
    Zeuli, M.
    Pizzi, G.
    Tropea, G.
    Sperduti, I
    Ettorre, G. M.
    Cognetti, F.
    ANNALS OF ONCOLOGY, 2009, 20
  • [2] CETUXIMAB (CMAB) PLUS CPT-11/5-FLUOROURACIL (5-FU)/LEUCOVORIN(FA)/OXALIPLATIN (L-OHP) (CPT-11-FFL) IN UNRESECTABLE COLORECTAL LIVER METASTASES (CLM): POCHER TRIAL TOXICITY RESULTS
    Torsello, A.
    Garufi, C.
    Tumolo, S.
    Mottolese, M.
    Campanella, C.
    Zeuli, M.
    Sperduti, I
    Pizzi, G.
    Ettorre, G.
    ANNALS OF ONCOLOGY, 2009, 20 : 62 - 63
  • [3] POCHER (preoperative chemotherapy for hepatic resection) with cetuximab (Cmab) plus CPT-11/5-fluorouracil (5-FU)/leucovorin(FA)/oxaliplatin (L-OHP) (CPT-11-FFL) in unresectable colorectal liver metastases (CLM)
    Garufi, C.
    Torsello, A.
    Tumolo, S.
    Mottolese, M.
    Campanella, C.
    Zeuli, M.
    Lo Re, G.
    Sperduti, I.
    Pizzi, G.
    Ettorre, G. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] CPT-11/5-fluorouracil(5-FU)/leucchorin (FA)/oxaliplatin (L-OHP) (CPT-11-FFL) plus cetuximab (Cmab) in unselectecl advanced colorectal cancer (ACC) patients.
    Garufi, C.
    Torsello, A.
    Campanella, C.
    Ettorre, G. M.
    Vennarecci, G.
    Melucci, E.
    Zeuli, M.
    Sperduti, I.
    Gelibter, A.
    Cognetti, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] Neoadjuvant chemotherapy with cetuximab plus a CPT-11/5-fluorouracil/leucovorin/oxaliplatin combination in colorectal liver metastases
    Garufi, Carlo
    Tumolo, Salvatore
    Torsello, Angela
    Vanni, Barbara
    Campanella, Carla
    Zeuli, Massimo
    Carpanese, Livio
    Mottolese, Marcella
    Grazia, Maria
    Pizzi, Diodoro Giuseppe
    Terzoli, Edmondo
    Ettorre, Giuseppe Maria
    ANNALS OF ONCOLOGY, 2007, 18 : 9 - 9
  • [6] Weekly administration of 5-fluorouracil (5-FU), folinic acid (FA), oxaliplatin (L-OHP) and irinotecan (CPT-11) [FUFOXIRI] for patients with metastatic gastric or colorectal cancer
    Harba, A
    Peinert, S
    Grothe, W
    Jordan, K
    Kegel, T
    Mueller, LP
    Behrens, R
    Grothey, A
    Arnold, D
    Schmoll, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 300S - 300S
  • [7] A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
    Oliver F Bathe
    Scott Ernst
    Francis R Sutherland
    Elijah Dixon
    Charles Butts
    David Bigam
    David Holland
    Geoffrey A Porter
    Jennifer Koppel
    Scot Dowden
    BMC Cancer, 9
  • [8] Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
    C Garufi
    A Torsello
    S Tumolo
    G M Ettorre
    M Zeuli
    C Campanella
    G Vennarecci
    M Mottolese
    I Sperduti
    F Cognetti
    British Journal of Cancer, 2010, 103 : 1542 - 1547
  • [9] Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial
    Garufi, C.
    Torsello, A.
    Tumolo, S.
    Ettorre, G. M.
    Zeuli, M.
    Campanella, C.
    Vennarecci, G.
    Mottolese, M.
    Sperduti, I.
    Cognetti, F.
    BRITISH JOURNAL OF CANCER, 2010, 103 (10) : 1542 - 1547
  • [10] A phase II study of neoadjuvant irinatecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for resectable liver metastases from colorectal cancer.
    Bathe, OF
    Ernst, S
    Sutherland, F
    Dixon, E
    Koppel, J
    Butts, C
    Bigam, D
    Ruether, D
    Walley, B
    Dowden, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 286S - 286S
12345